Health Condition 1: O- Medical and Surgical Health Condition 2: N859- Noninflammatory disorder of uterus, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Premenopausal women with regular menstrual cycles that are undergoing opportunistic salpingectomy for benign reasons with normal baseline ovarian reserve and are willing to participate in the trial
Exclusion criteria
Exclusion criteria: Patients that have undergone any ovarian, tubal or gynecological surgery or presence of any gynaecological pathology like PCOS malignancy or endometrioma. Women who are on hormonal pills for the past 3 months or who have known infertility. Post menopausal women and women who have underwent hysterectomy with unilateral or bilateral oopherectomy or salpingo oopherectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The vascular supply to the ovaries is largely preserved when salpingectomy is performed carefully. Hence, no early menopause or hormonal dysfunction has been. Helps reduce the cancer burden.It is a cost-neutral or low-cost addition to routine surgeries. Timepoint: FSH, LH and AMH will be measured at baseline level and then after salpingectomy and after 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Uttar Pradesh university of medical sciences